-+ 0.00%
-+ 0.00%
-+ 0.00%

Elicio Therapeutics Reports Robust T Cell Responses in Phase 2 Trial of ELI-002 7P for KRAS-Mutant Pancreatic Cancer

Reuters·11/07/2025 14:00:44

Please log in to view news